Business Context and Reporting Period
This Form 6-K filing by Prana Biotechnology Limited (ASX: PBT) reports the results of the 2011 Annual General Meeting held on November 29, 2011. The registrant is an Australian biotechnology company. Note: The request metadata references "Alterity Therapeutics Ltd," but the filing text explicitly identifies the registrant as Prana Biotechnology Limited.
Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This document is a corporate governance report regarding shareholder voting outcomes and does not contain financial statements.
Material Changes
No material financial changes are reported in this filing. The document focuses solely on the voting results of the Annual General Meeting.
Guidance, Outlook, and Management Commentary
The filing details the unanimous passage of all resolutions on a show of hands. Specific voting outcomes include:
- Resolution 1 (Re-Election of Mr. Peter Marks as Director): Carried with 44,902,434 votes For, 454,230 Against, and 3,179,770 Abstentions out of a total of 52,212,727 votes.
- Resolution 2 (Non-Binding Adoption of Remuneration Report): Carried with 26,297,565 votes For, 4,594,360 Against, and 21,319,569 Abstentions out of a total of 52,975,197 votes. Approximately 84% of proxies received voted in favor.
The Chairman voted undirected proxies in favor of all resolutions, except for Resolution 2, where the Chairman abstained.
Key Facts for Investor Verification
- Verify the correct registrant name is Prana Biotechnology Limited, not Alterity Therapeutics Ltd.
- Confirm the re-election of Mr. Peter Marks as a Director was approved by shareholders.
- Note that the Remuneration Report received significant support (84% of proxies) despite a high number of abstentions.
- Recognize that this filing contains no financial performance data for the period.